10 Top Penny Stocks To Watch This Week With Potential Biotech Catalysts

Asia's Tech News Daily

Are These The Best Penny Stocks To Watch This Week?

Here we are at the start of a new week and a new list of penny stocks to watch. This has become a frequent installment on our weekly outlook on markets with a focus on one industry. Biotechnology is one of the areas of the stock market with constant volatility. It doesn’t matter if we’re talking about cheap stocks on Robinhood under $5 or large-cap stocks trading above $100.

stocks on Robinhood under $5, penny stocks, NASDAQ:SNGX, NASDAQ:RNAZ, NASDAQ:CTXR, NASDAQ:EVFM, NASDAQ:SIOX, NASDAQ:ABEO, NASDAQ:RSLS, NASDAQ:ADTX, NASDAQ:LGVN, NASDAQ:AVRO, list of penny stocks, penny stock to watch, NYSE:RDY, NYSE:AIM, NASDAQ:XCUR, NASDAQ:ABUS

PennyStocks.com – PennyStocks

Since this industry has oversight bodies like the Food And Drug Administration, certain things must be upheld based on rules that’ve been in place for decades. Part of this set of rules has to do with things like phase trials. Whether it’s pre-clinical, clinical, or commercial launch, steps are needed and proof required to move forward with any drug candidate or medical device.

There are also plenty of forms and applications that get filed along the way, allowing for FDA and other global biotech oversight groups to give guidance or even completely shut down a company’s pipeline development. Then you’ve got other things specific to companies unrelated to any FDA event.

Read more: 4 Hot OTC Penny Stocks To Watch For October 2021

These are things like industry conferences and investor engagements. The bottom line is, unlike other industries, biotech has plenty of moving parts that can act as catalysts in the stock market. Today we’ll look at 10 penny stocks to watch this week with potential biotech catalysts. Will they be on the buy- or avoid-side of your watch list?

Penny Stocks To Watch This Week

Company Date
1. Soligenix Inc. (NASDAQ:SNGX) October 18, 2021
2. Transcode Therapeutics Inc. (NASDAQ:RNAZ) October 19, 2021
3. Citius Pharmaceuticals Inc. (NASDAQ:CTXR) October 20, 2021

October 21, 2021
4. Evofem Biosciences Inc. (NASDAQ:EVFM) October 20, 2021
4. Sio Gene Therapies (NASDAQ:SIOX) October 21, 2021
5. Abeona Therapeutics (NASDAQ:ABEO) October 21, 2021
6. ReShape Lifesciences (NASDAQ:RSLS) October 21, 2021
7. Aditxt Inc. (NASDAQ:ADTX) October 21, 2021
8. Longeveron Inc. (NASDAQ:LGVN) October 21, 2021
10. AVROBIO Inc. (NASDAQ:AVRO) October 22, 2021

Penny Stocks To Watch On October 18:

Soligenix Inc. (NASDAQ:SNGX)

The first name on this list of penny stocks kicks things off tomorrow. Soligenix specializes in treatments for several indications. Its SGX301 (HyBryte) platform addresses cutaneous T-cell lymphoma and is awaiting regulatory approval after completing a Phase 3 study. Solivenix has also developed its SGX302 (Hypericin) in treating psoriasis.

Soligenix is also part of the popular COVID-19 vaccine grouping of stocks. The company is developing CiVax™, which is currently under observation in non-human primates. The vaccine candidate has shown protective effects against the SARS-CoV-2 variant and was recently featured in the article, “Protein Vaccine Induces a Durable, More Broadly Neutralizing Antibody Response in Macaques than Natural Infection with SARS-CoV-2 P.1.”

What To Watch With SNGX Stock This Week

This week is all about the HyBryte platform. An abstract was selected and accepted for display and presentation at the National Organization for Rare Disorders Rare Diseases and Orphan Products Breakthrough Summit. The company will present the positive Phase 3 results with HyBryte™ in the context of the broader cutaneous T-cell lymphoma treatment landscape. This Summit begins on October 18th.

stocks on Robinhood under $5, penny stocks, NASDAQ:SNGX, NASDAQ:RNAZ, NASDAQ:CTXR, NASDAQ:EVFM, NASDAQ:SIOX, NASDAQ:ABEO, NASDAQ:RSLS, NASDAQ:ADTX, NASDAQ:LGVN, NASDAQ:AVRO, list of penny stocks, penny stock to watch, NYSE:RDY, NYSE:AIM, NASDAQ:XCUR, NASDAQ:ABUS

Penny Stocks To Watch On October 19:

Transcode Therapeutics Inc. (NASDAQ:RNAZ)

This week will be a very active week of conference presentations, as you’ll see in the next section. Transcode Therapeutics will have a presence at one of these conferences early during the week.

Read more: 5 Top Penny Stocks Analysts Say To Buy With 119%-430% Price Targets

The company went public earlier this summer and has since fought back to regain its IPO levels unsuccessfully. Transcode is developing RNA oncology treatments targeting multiple indications. Its lead therapeutic candidate, TTX-MC138, is under development for addressing metastatic cancer. According to the company, TTX-MC138 has the potential to produce regression without recurrence in a wide range of cancers such as breast, pancreatic, ovarian, and colon cancer, as well as glioblastomas.

What To Watch With RNAZ Stock This Week

The company recently appointed scientific co-founder of TransCode, Zdravka Medarova, Ph.D., as Chief Technology Officer. Dr. Medarova presents on Day 2 (Oct. 19) of the International OligonucIeotides and Peptides Conference. Her segment begins in the afternoon on Tuesday. So that could be something to keep in mind if RNAZ stock is on your watch list right now.

stocks on Robinhood under $5, penny stocks, NASDAQ:SNGX, NASDAQ:RNAZ, NASDAQ:CTXR, NASDAQ:EVFM, NASDAQ:SIOX, NASDAQ:ABEO, NASDAQ:RSLS, NASDAQ:ADTX, NASDAQ:LGVN, NASDAQ:AVRO, list of penny stocks, penny stock to watch, NYSE:RDY, NYSE:AIM, NASDAQ:XCUR, NASDAQ:ABUS

Penny Stocks To Watch On October 20:

Citius Pharmaceuticals Inc. (NASDAQ:CTXR)

Since the start of the year, Citus Pharmaceuticals has been a penny stock to watch. The company’s shares kicked things off at $1.05 in January and ended up running to highs of over $4.50 at one point this year. The company’s Mino-Lok platform has been one of the core points of focus for the market. This is a treatment for patients with catheter-related bloodstream infections. It’s currently in a Phase 3 Pivotal superiority trial. The FDA has also granted Fast-Track designation for the candidate.

The company’s I/ONTAK (E7777) is another treatment candidate targeting cutaneous T-cell lymphoma that has completed enrollment in a Phase 3 trial. The FDA granted this treatment orphan drug designation as well.

What To Watch With CTXR Stock This Week

This week is a busy one for Citius. First, the company hosts a webcast on October 20th. Executive Chairman Leonard Mazur and Chief Medical Officer Dr. Myron Czuczman join CEO Myron Holubiak. The team discusses Cituis’ strategy and opportunities with I/ONTAK. A day later, on October 21, management discusses its pipeline of therapies, including the two late-stage treatments in Phase 3 trials. The company also plans on discussing its stem cell therapy program in development through the company’s NoveCite, Inc subsidiary.

stocks on Robinhood under $5, penny stocks, NASDAQ:SNGX, NASDAQ:RNAZ, NASDAQ:CTXR, NASDAQ:EVFM, NASDAQ:SIOX, NASDAQ:ABEO, NASDAQ:RSLS, NASDAQ:ADTX, NASDAQ:LGVN, NASDAQ:AVRO, list of penny stocks, penny stock to watch, NYSE:RDY, NYSE:AIM, NASDAQ:XCUR, NASDAQ:ABUS

Evofem Biosciences (NASDAQ:EVFM)

It hasn’t been a pleasant last few months for Evofem. A mix of financing deals has been some of the hurdles faced in the market. EVFM stock has dropped from over $2 at the start of Q2 to as low as $0.6543 in August. Since reaching those lows, the penny stock treaded water around $0.75-$0.80.

Read more: Popular Penny Stocks to Buy in October? 3 For Your Watchlist

Will Evofem be able to turn things around? The company’s portfolio of women’s STI treatments has been the core focus. Its Phexxi is the company’s first commercial product currently marketed as a female contraceptive. Additionally, the company’s EVO100 is under evaluation for the prevention of chlamydia and gonorrhea.

What To Watch With EVFM Stock This Week

Despite its performance in the market, there are still a few things to know about the company if EVFM stock is still on your radar. The company delivers details on numerous abstracts at the American Society for Reproductive Medicine Scientific Congress on October 20. It will also give more information at the International Federation of Gynecology and Obstetrics XXIII World Congress of Obstetrics and Gynecology. Whether or not this helps turn things around is to be seen but is a highlight coming into the second half of October.

stocks on Robinhood under $5, penny stocks, NASDAQ:SNGX, NASDAQ:RNAZ, NASDAQ:CTXR, NASDAQ:EVFM, NASDAQ:SIOX, NASDAQ:ABEO, NASDAQ:RSLS, NASDAQ:ADTX, NASDAQ:LGVN, NASDAQ:AVRO, list of penny stocks, penny stock to watch, NYSE:RDY, NYSE:AIM, NASDAQ:XCUR, NASDAQ:ABUS

Penny Stocks To Watch On October 21:

Sio Gene Therapies (NASDAQ:SIOX)

Sio Gene’s pipeline focuses on neurodegenerative diseases and includes gene therapies for gangliosidosis and Tay-Sachs/Sandhoff diseases. Its AXO-AAV-GM1 and GM2 are the primary treatment platforms under development. GM1, in particular, has also received Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA. Additionally, the company’s AXO-Lenti-PD is in trials for treating Parkinson’s disease.

What To Watch With SIOX Stock This Week

Heading into mid-week, the company presents at the European Society of Gene & Cell Therapy Virtual Congress. This isn’t just a presentation on the broader strokes of the company; Managemen presents new clinical and preclinical data in 2 oral presentations and one poster presentation. These will include an update on the Phase 1/2 trial of AXO-AAV-GM1 in Typ 1 and Type 2 GM1 gangliosidosis. Sio Gene also presents a poster review of data from its Phase 1/2 study of AXO-Lenti-PD.

stocks on Robinhood under $5, penny stocks, NASDAQ:SNGX, NASDAQ:RNAZ, NASDAQ:CTXR, NASDAQ:EVFM, NASDAQ:SIOX, NASDAQ:ABEO, NASDAQ:RSLS, NASDAQ:ADTX, NASDAQ:LGVN, NASDAQ:AVRO, list of penny stocks, penny stock to watch, NYSE:RDY, NYSE:AIM, NASDAQ:XCUR, NASDAQ:ABUS

Abeona Therapeutics (NASDAQ:ABEO)

Abeona could be another one of the penny stocks to watch this week. The company’s current programs include its EB-101, a Phase 3 candidate in treating dystrophic epidermolysis bullosa. It’s also developing ABO-102 and ABO-101 for Sanfilippo syndrome types A and B in Phase 1/2.

What To Watch With ABEO Stock This Week

Similar to SIOX, ABEO stock could be in focus this week as it presents clinical data. The company’s pivotal trial of ABO-102 will be the focus at the Congress of European Society of Gene & Cell Therapy. This comes just one week after Abeona presented data from its Phase 1/2a EB-101 trial at the Pediatric Dermatology Research Alliance Conference.

stocks on Robinhood under $5, penny stocks, NASDAQ:SNGX, NASDAQ:RNAZ, NASDAQ:CTXR, NASDAQ:EVFM, NASDAQ:SIOX, NASDAQ:ABEO, NASDAQ:RSLS, NASDAQ:ADTX, NASDAQ:LGVN, NASDAQ:AVRO, list of penny stocks, penny stock to watch, NYSE:RDY, NYSE:AIM, NASDAQ:XCUR, NASDAQ:ABUS

ReShape Lifesciences (NASDAQ:RSLS)

The second half of the week will also see several of the following companies mentioned present at the same conference. The company has benefited from recent attention stemming from the analyst community. Maxim Group initiated coverage on ReShape earlier this month. The firm started RSLS stock with a Buy rating and an $8 price target (See: Best Penny Stocks To Buy According To Analysts & Targets Up To 290%).

The company designs medical devices for weight loss and metabolic health. Its FDA-approved Lap-Band Program allows for minimally invasive treatment for obesity. ReShape’s “ReShape Vest System” is an investigational laparoscopically implanted device that wraps around the stomach and is used for weight loss. Last week the company launched a national ad campaign for Lap-Band, which includes spots on HGTV, TLC, Bravo, People Magazine, and Good Housekeeping, to name a few.

What To Watch With RSLS Stock This Week

This week, amid the media blitz, ReShape also presents at an investor-focused conference. The company is one of nearly 40 listed as presenters at the Dawson James Small Cap Growth Conference.

stocks on Robinhood under $5, penny stocks, NASDAQ:SNGX, NASDAQ:RNAZ, NASDAQ:CTXR, NASDAQ:EVFM, NASDAQ:SIOX, NASDAQ:ABEO, NASDAQ:RSLS, NASDAQ:ADTX, NASDAQ:LGVN, NASDAQ:AVRO, list of penny stocks, penny stock to watch, NYSE:RDY, NYSE:AIM, NASDAQ:XCUR, NASDAQ:ABUS

Aditxt Inc. (NASDAQ:ADTX)

Aditxt is another presenter listed at a conference this week. The company just came off of a presentation last week at the LD Micro Main Event on Wednesday. In focus has been the recent acquisition of AiPharma, which holds rights to an antiviral tablet Avigan/Reeqonus/Qifenda. Furthermore, AiPharma is part of a consortium called Global Response Aid.

It’s made up of companies including Dr. Reddy’s Laboratories (NYSE:RDY), Appili Therapeutics, and even a subsidiary of FujiFilm Holdings, FujiFilm Toyama Chemical, to name a few. Appili Therapeutics is running a global Phase 3 trial evaluating Avigan/Reeqonus as an oral at-home therapy for COVID-19. Completed enrollment in this trial was also recently announced, with top-line data expected in a few months.

“The successful completion of this acquisition would accelerate our commercialization plans in the infectious disease space and would uniquely position Aditxt by combining our commercialized AditxtScore™ for COVID-19 test with an at-home treatment for the disease. While initially targeting COVID-19, our combined clinical and commercial platform would potentially address unmet needs in other viral indications.”

Amro Albanna, Aditxt Co-Founder and CEO

What To Watch With ADTX Stock This Week

Aditxt is another one of the company’s listed on the roster of the Dawson James Small Cap Growth Conference. In addition to this acquisition, another topic of discussion has been the company’s AditxtScore for COVID-19. With more attention on COVID-related names and more presentations, it will be interesting to see what’s next for ADTX stock.

stocks on Robinhood under $5, penny stocks, NASDAQ:SNGX, NASDAQ:RNAZ, NASDAQ:CTXR, NASDAQ:EVFM, NASDAQ:SIOX, NASDAQ:ABEO, NASDAQ:RSLS, NASDAQ:ADTX, NASDAQ:LGVN, NASDAQ:AVRO, list of penny stocks, penny stock to watch, NYSE:RDY, NYSE:AIM, NASDAQ:XCUR, NASDAQ:ABUS

Longeveron Inc. (NASDAQ:LGVN)

The focus for Longeveron is developing cell therapies for conditions such as aging frailty, Alzheimer’s disease, metabolic syndrome, and acute respiratory distress syndrome, among other things. Its LOMECEL-B platform derives medicinal signaling cells from the bone marrow of younger healthy adult donors. The idea is that by using cells that promote tissue repair, organ maintenance, and immune function, therapies can be efficiently developed for age-related disorders.

What To Watch With LGVN Stock This Week

Longeveron presents at the Dawson James conference this week. Beginning at 11:25 AM ET, management will discuss its platform and conduct one-on-one meetings. If LGVN stock is on your list, this may be an important date to keep in mind.

stocks on Robinhood under $5, penny stocks, NASDAQ:SNGX, NASDAQ:RNAZ, NASDAQ:CTXR, NASDAQ:EVFM, NASDAQ:SIOX, NASDAQ:ABEO, NASDAQ:RSLS, NASDAQ:ADTX, NASDAQ:LGVN, NASDAQ:AVRO, list of penny stocks, penny stock to watch, NYSE:RDY, NYSE:AIM, NASDAQ:XCUR, NASDAQ:ABUS

Penny Stocks To Watch On October 22:

AVROBIO Inc. (NASDAQ:AVRO)

Though it’s just out of the penny stock range, AVROBIO is one of the lower-priced biotech stocks to watch this week. The company specializes in gene therapies for treating genetic diseases such as Fabry disease, Gaucher disease type 1, and cystinosis. There are also preclinical programs in Hunter syndrome, Gaucher disease type 3, and Pompe disease.

What To Watch With AVRO Stock This Week

AVROBIO also has a busy week ahead. On October 20, the company sponsors a symposium on “Advancing the patient experience during ex vivo lentiviral gene therapy for lysosomal disorders.” Following this, on October 21, it presents new safety data from its clinical trials in Fabry disease and Gaucher disease type 1 at the Congress of the European Society of Gene & Cell Therapy.

Read more: Top Penny Stocks to Watch As BTC Passes $61,000

These include a presentation by Senior Scientist Mariana Loperfido, Ph.D., who discusses specifics on the company’s lentiviral gene therapy in lysosomal disorders. Principal investigator of the AVROBIO-sponsored FAB-GT Phase 2 trial, Mark Thomas, M.D., presents safety data on 8 Fabry disease patients in the trial treated with AVR-RD-01.

stocks on Robinhood under $5, penny stocks, NASDAQ:SNGX, NASDAQ:RNAZ, NASDAQ:CTXR, NASDAQ:EVFM, NASDAQ:SIOX, NASDAQ:ABEO, NASDAQ:RSLS, NASDAQ:ADTX, NASDAQ:LGVN, NASDAQ:AVRO, list of penny stocks, penny stock to watch, NYSE:RDY, NYSE:AIM, NASDAQ:XCUR, NASDAQ:ABUS

BONUS: Penny Stocks To Watch

Are you still looking for more penny stocks to watch this week with potential catalysts? Here’s the bonus round of this article:

AIM ImmunoTech Inc. (NYSE:AIM) – October 18, 2021

AIM announced its final protocol for a planned Phase 2 study of its Ampligen drug as a therapy for locally advanced or metastatic late-stage pancreatic cancer. In an early October release, the company said that it expects to submit both an Investigational New Drug application and an application for Fast Track status with the FDA no later than October 18, 2021.

No further updates have been made since. So this could be a scenario where the clock is ticking for the company. This comes on the heels of recently published Phase 1 study data supporting the safety of its Ampligen therapy as an intranasal therapeutic for COVID-19.

Exicure Inc. (NASDAQ:XCUR) – October 18, 2021

Monday, Exicure’s COO Matthias Schroff presents at the International OligonucIeotides and Peptides Conference. The title of the presentation is “Spherical Nucleic Acids Facilitate Efficient Local Delivery Across Therapeutic Areas.”

Arbutus Biopharma Corporation (NASDAQ:ABUS) – Second Half Of 2021

While no specific date was announced, earlier this year, Arbutus initiated a Phase 1a/1b clinical trial with AB-836. This is Arbutus’ proprietary oral capsid inhibitor. The company explained that initial data is expected in the second half of the year.

Best Penny Stocks To Buy [or avoid]

Are these the best penny stocks to buy right now? Knowing what’s coming down the road is a valuable asset to have in your arsenal. But, it’s also important to understand that just because there is an actual update coming, that doesn’t mean it’s guaranteed to be a positive one. Make sure to keep this in mind, especially when it comes to biotech stocks.

Internet Explorer Channel Network
Asia's Tech News Daily
News Related

OTHER NEWS

Unions plan for national rail strike as job cuts loom

Photograph: Amer Ghazzal/REX/Shutterstock ‘Attacks on pay and pensions’ also expected after Department of Transport tells industry to find savings of 10% Rail unions are drawing up plans for a national ... Read more »

The robot Sophia will now exist in the physical and virtual worlds within the metaverse.

Metaverses are becoming more and more popular, little by little more people and investors are getting involved. This time, the news is that the famous humanoid robot, Sophia , will ... Read more »

Organ grinders digitize their tips to rescue tradition

In Mexico there is a tradition that clings tooth and nail to avoid extinction: the organ grinders . It is difficult to imagine a Sunday afternoon down Alameda Central or ... Read more »

Three Pfizer Vaccine Shots Can Neutralize Omicron Variant

Pfizer Inc (NYSE:PFE) said Wednesday that three shots of its vaccine are effective at neutralizing the Omicron variant of COVID-19. The information stems from a laboratory test the pharma giant ... Read more »

Tax credit aimed at low- to middle-income workers was expanded amid Covid-19. Who stands to benefit most

Joe Amon | MediaNews Group | Denver Post | Getty Images A temporary expansion of a tax credit aimed at workers with low to moderate pay could be extended for ... Read more »

Monzo valuation jumps to $4.5 billion after fresh funding round

A Monzo logo is seen in this illustration LONDON (Reuters) -British digital bank Monzo has completed a fresh funding round valuing the company at $4.5 billion, in a vote of ... Read more »

Elon Musk slams Biden's Build Back Better bill and its electric car incentives

Photograph: Mike Blake/Reuters Elon Musk criticized new incentives and infrastructure for electric vehicles in a huge spending bill backed by Joe Biden, saying he would “delete” the measures and even ... Read more »

Sandeep Kumar Sultania ceases to be chief financial officer of Srei Infrastructure Finance

Srei Infrastructure Finance on Wednesday said Sandeep Kumar Sultania has ceased to be the company’s chief financial officer (CFO). “Sandeep Kumar Sultania has ceased to be the chief financial officer ... Read more »

Top tips to prep your portfolio for 2022

Investors saw it all in 2021. Next year promises a little more upside, according to two top strategists. “Aside from the latest variant, and Covid in general, the underlying economy ... Read more »

What Interior Designers Need to Know About Digital Marketing Sales and Lead Generation

The sales funnel map is part of the customer’s journey. It is composed of digital products intentionally created to encourage your website’s visitors to take specific actions at each stage of ... Read more »

FTSE cools on Omicron fears

Traders had a subdued day after 48 hours of expectations rising that the Omicron variant of Covid-19 may not be as concerning as first thought. But rising case numbers and ... Read more »

Scoop Up Big Gains With 4 Stocks Enjoying Rising Cash Flows

Making profits is undoubtedly a company’s primary goal, but having a healthy cash flow is imperative to its existence, development and success. And why not? Even a company generating profits ... Read more »

Are Options Traders Betting on a Big Move in Globalstar (GSAT) Stock?

Investors in Globalstar, Inc. GSAT need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 23, 2021 $1.50 Call ... Read more »

Coronavirus Stimulus Checks to Workers: Your Job May Get You Some COVID Relief Cash

More federal stimulus checks are unlikely to come, but there are a few groups that are getting targeted payments from their state or local government. One such group is workers ... Read more »

Implied Volatility Surging for Invitae (NVTA) Stock Options

Investors in Invitae Corporation NVTA need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 21, 2022 $40.00 Put ... Read more »

Here's Why Hold is an Apt Strategy for AXIS Capital (AXS)

AXIS Capital Holdings Limited AXS is poised for growth on solid Specialty Insurance, Reinsurance plus Accident and Health insurance portfolio, exit from underperforming lines, investment in more attractive markets, and ... Read more »

Pay Attention To Microcap Oil-Dri Corporation 

Supply Chain Costs Are Still Rising For Oil-Dri Corporation  Oil-Dri Corporation (NYSE: ODC) is not a big company but it is representative of an issue that has been and is ... Read more »

Kinsale (KNSL) Gains 33% in 6 Months: More Room for Upside?

Shares of Kinsale Capital Group KNSL have rallied 32.6% in the last six months against the industry’s decrease of 8.6% and the Finance sector’s decrease of 0.7%. The S&P 500 ... Read more »

Stock Market News for Dec 8, 2021

U.S. stocks closed higher for the second consecutive session on Tuesday as investors shrugged off fears of the Omicron variant of the coronavirus after reports suggested that the mutant is ... Read more »

How to Introduce Customer Financing in Your Business

If you’re going to sell expensive items to customers, you should be prepared to offer your customers some form of financing. Once offered, your customers can take advantage of loans ... Read more »

Company News for Dec 8, 2021

Shares of American Airlines Group Inc. AAL declined 0.2% after the company said that its Chief Executive Officer Doug Parker will retire on Mar 31, 2022 after being in the ... Read more »

Lockheed's (LMT) Arm Wins Deal to Support CH-53K Aircraft

Lockheed Martin Corp.’s LMT business unit, Sikorsky, recently won a contract for procuring long-lead items involving full-rate production of CH-53K aircraft. The Naval Air Systems Command, Patuxent River, MD, offered ... Read more »

Are Options Traders Betting on a Big Move in Sesen Bio (SESN) Stock?

Investors in Sesen Bio, Inc. SESN need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 18, 2022 $2.00 ... Read more »

GATX Selects Lyons as New CEO, Incumbent to Retire in '22

GATX Corporation’s GATX president and CEO, Brian A. Kenney, is set to retire on Apr 22, 2022. He will continue to serve on GATX’s board of directors as non-executive chairman ... Read more »

Growing Pains Cut Into Casey's General Stores, Inc Profits

Inflation Takes A Bite Out Of Casey’s General Stores  Casey’s General Stores, Inc (NASDAQ: CASY) is a solid post-pandemic play and steady growth story and nothing has changed about that. ... Read more »

Bill Gates Gets Emotional About Divorce, Empty Nesting: 'It's Been a Year of Great Personal Sadness For Me'

Never one to publicly overshare about his personal life, Bill Gates took to his blog on Tuesday to share some insight on his emotions following a very heartbreaking divorce as ... Read more »

Australian house prices will keep rising and it's truly depressing for those hoping to get into the market

Photograph: Bloomberg/Getty Images In news that unfortunately will shock no one who has thought about buying a house at any point in the past year or so, the latest residential ... Read more »

Pound tumbles to 2021 low over fears of new Plan B virus curbs

Speculation that the Government could launch new Plan B coronavirus restrictions have caused the pound to drop to its lowest level in 2021 and weighed heavily on UK leisure firms. ... Read more »

Google's 2021 search list: Bernie Sanders ‘mittens' and Squid Game top the trends

Photograph: Brendan Smialowski/AFP/Getty Images Annual list reveals most searched-for terms globally related to sports, investing, Covid and skinny jeans Squid Game, Bernie Sanders’ mittens and how to wear skinny jeans, ... Read more »

New laser breakthrough could allow scientists to transform materials just using light

(Independent) Scientists say they have made a major step towards being able to transform materials using just light. The new breakthrough is a step towards the creation of things such ... Read more »

City watchdog reveals tech recruitment woes

Britain’s City watchdog has become the latest victim of the growing recruitment crisis in the UK as it revealed struggles to hire in-demand technology specialists. Financial Conduct Authority (FCA) chief ... Read more »

Former Theranos CEO Elizabeth Holmes Admits to Inaccuracies in Her First Major Cover Story

On Tuesday, U.S. attorney Robert Leach continued his cross-examination of former Theranos CEO Elizabeth Holmes in her fraud trial after a one-week recess. At one point during the testimony, Leach questioned ... Read more »

Google's Year in Search 2021 Was Led by Sports and 'Squid Games,' But Other Trending Topics Might Surprise You

Google just released its Year in Search for 2021, and it includes some predictable topics in the top slots. Sports took up the top five overall with searches like “Australia vs ... Read more »

Why this month echoes December 2018 when stocks plummeted, according to top strategist

It's been a wild few weeks for markets. A sell-off last week dragged stocks sharply lower with the emergence of the omicron variant of the coronavirus, a more hawkish Federal ... Read more »

To Become a Top Executive, Take Control of Your Personal Brand Today

In today’s search-engine era, numerous search platforms make it easier than ever to find out all you could ever need to know about products, businesses or even personal information about senior-level ... Read more »

From CTV to Programmatic Product Placements: Marketing Trends to Embrace in 2022

The digital marketing landscape has been increasingly dynamic, to put it mildly. Pandemic-related restrictions and data security/privacy regulations made hundreds of companies the reexamine old strategies and platforms for ad ... Read more »

Why You Should Look Into Luxury Niches and Micro-Influencer Marketing

Targeting a niche of clients is the first step in building a strong digital brand for your design business. Unique luxury niches such as yachting and private aviation interior design can level ... Read more »

A song called 'Startup' that your marketing strategy can compose in 2022

By Daniel Munar, Office Manager Colombia & México at Wayra Hispam When we talk about undertaking and entering the world of innovation , we can say that it is the ... Read more »

Bitcoin: Self-proclaimed creator wins right to keep $50B BTC fortune he claims to own

US Bitcoin Trial (Copyright 2021 The Associated Press. All Rights Reserved.) A computer scientist who claims to be the inventor of bitcoin has won a legal battle to keep hold ... Read more »

HelloFresh to double investments in 2022 as stock dives

BERLIN (Reuters) – German meal-kit operator HelloFresh plans to double its investments in production capacity, infrastructure and product development to about 450 – 550 million euros ($508.73 million to $621.78 ... Read more »
On free-english-test.com you will find lots of free English exam practice materials to help you improve your English skills: grammar, listening, reading, writing, ielts, toeic